Treating Platinum-resistant Ovarian Cancer and Advanced Cervical Cancer with AVASTIN

Date: Tuesday, January 20, 2015

Arrival Time: 6:00 PM Central Time

Presentation Time: 6:30 PM Central Time

Location: Broadway 1 0 Bar & Chophouse

                 1101 North Broadway Avenue, Suite 101

                 Oklahoma City, OK 73103

Audience: This oncology program has been developed for physician peer-to-peer discussion and participation.

Program Overview: The goal of this program is to describe the indication and proposed mechanism of action for Avastin® (bevacizumab) and review efficacy and safety data of platinum-resistant ovarian cancer and advanced cervical cancer.

Presented by: John Farley, M D

                        St. Joseph’s Hospital and Medical Center

                        Phoenix, AZ

Hosted by: Lindsey Baker, Genentech

To RSVP: Visit or contact Lindsey Baker at 405-819-9312 or Baker.Lindsey@Gene.Com

Event Code: MF01904

* Click on article title for more information.


No comments have been posted yet.